Effects of Intensified Sodium Management in Hemodialysis Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The primary aim of this study is to investigate whether intensive sodium management by dietary sodium restriction and by preventing positive sodium balance during dialysis can be successfully applied in chronic hemodialysis patients. Secondary aims are to test if sodium restriction has positive effects on the frequency of hospital admissions, blood pressure, fluid overload, quality of life and residual renal function.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Ambulatory, clinically stable maintenance hemodialysis patients on a thrice weekly HD regimen.
Willing and able to provide written, signed informed consent after the nature of the study has been explained.
Willing and able to comply with all study procedures.
Age ≥18 years.
Simultaneous participation in another clinical study except observational trials.
Any psychological condition which could interfere with the patient's ability to comply with the study protocol.
Amputation of a limb.
Pacemaker, implantable pump, artificial joint.
Expectation that native kidney function will recover.
Unable to verbally communicate in English or Spanish.
Scheduled for living donor kidney transplant, change to peritoneal dialysis, home HD or plans to relocate to another center within the next 14 months.